Financial statements Biokod Lab
Balance sheet data of BIOKOD LAB
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 148 194,92 | 195 193,06 | 262 003,38 | 279 040,30 | 176 113,92 | 139 666,39 |
A. Fixed assets | 38 441,30 | 114 239,81 | 219 424,63 | 214 065,01 | 171 079,93 | 127 740,84 |
B. Current assets | 109 753,62 | 80 953,25 | 42 578,75 | 64 975,29 | 5 033,99 | 11 925,55 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Total liabilities | 148 194,92 | 195 193,06 | 262 003,38 | 279 040,30 | 176 113,92 | 139 666,39 |
A. Equity | 115 892,37 | 172 246,08 | 128 256,04 | 244 074,76 | 160 555,53 | 68 801,76 |
B. Liabilities and provisions for liabilities | 32 302,55 | 22 946,98 | 133 747,34 | 34 965,54 | 15 558,39 | 70 864,63 |
I. Long-term liabilities | 1 100,00 | 1 100,00 | 95 602,64 | 15 000,00 | 9 747,71 | 0,00 |
II. Short-term liabilities | 30 660,55 | 14 435,48 | 38 144,70 | 19 965,54 | 5 810,68 | 70 864,63 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.